Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.600 | None | 0.950 | 58 | 0 | 1990 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.700 | None | 0.960 | 36 | 0 | 1994 | 2020 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
disease | 0.400 | None | 0.987 | 25 | 0 | 1997 | 2019 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.500 | None | 0.979 | 24 | 0 | 1984 | 2020 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
disease | 0.400 | None | 0.972 | 16 | 0 | 1996 | 2019 | ||||||||
|
cadherin 1 | 0.401 | 0.808 | 0.15 |
|
disease | 0.400 | None | 1.000 | 16 | 0 | 1998 | 2018 | ||||||||
|
cyclin dependent kinase inhibitor 1A | 0.403 | 0.769 | 1.9E-03 |
|
disease | 0.100 | None | 0.968 | 15 | 0 | 1997 | 2013 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
disease | 0.400 | None | 0.988 | 14 | 0 | 1989 | 2019 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
disease | 0.400 | None | 0.971 | 11 | 0 | 2001 | 2019 | ||||||||
|
matrix metallopeptidase 2 | 0.333 | 0.923 | 0.84 |
|
disease | 0.100 | None | 1.000 | 9 | 0 | 1995 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 1B | 0.409 | 0.769 | 0.62 |
|
disease | 0.100 | None | 1.000 | 9 | 0 | 2001 | 2008 | ||||||||
|
mutL homolog 1 | 0.399 | 0.808 | 3.4E-05 |
|
disease | 0.100 | None | 1.000 | 9 | 0 | 2000 | 2015 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
disease | 0.400 | None | 1.000 | 9 | 0 | 1994 | 2018 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
disease | 0.100 | None | 0.965 | 8 | 0 | 1990 | 2019 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.300 | None | 0.869 | 8 | 0 | 1994 | 2019 | ||||||||
|
C-X-C motif chemokine receptor 4 | 0.362 | 0.923 | 1.8E-02 |
|
disease | 0.100 | None | 1.000 | 8 | 0 | 2003 | 2019 | ||||||||
|
tumor protein p63 | 0.362 | 0.769 | 1.00 |
|
disease | 0.400 | None | 0.963 | 8 | 0 | 2001 | 2020 | ||||||||
|
marker of proliferation Ki-67 | 0.431 | 0.808 | 1.3E-28 |
|
disease | 0.100 | None | 0.933 | 7 | 0 | 1996 | 2019 | ||||||||
|
matrix metallopeptidase 3 | 0.408 | 0.885 | 5.7E-15 |
|
disease | 0.100 | None | 1.000 | 7 | 0 | 1994 | 2017 | ||||||||
|
serpin family B member 3 | 0.565 | 0.615 | 8.2E-16 |
|
disease | 0.400 | None | 1.000 | 7 | 0 | 2001 | 2018 | ||||||||
|
S-phase kinase associated protein 2 | 0.492 | 0.808 | 0.96 |
|
disease | 0.100 | None | 1.000 | 6 | 0 | 2001 | 2018 | ||||||||
|
tumor protein p73 | 0.449 | 0.808 | 1.00 |
|
disease | 0.100 | None | 0.923 | 6 | 0 | 1998 | 2016 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
disease | 0.400 | None | 0.976 | 6 | 0 | 2002 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
disease | 0.400 | None | 1.000 | 6 | 0 | 2001 | 2020 | ||||||||
|
mutS homolog 2 | 0.406 | 0.808 | 0.90 |
|
disease | 0.100 | None | 1.000 | 6 | 0 | 2000 | 2019 |